Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 769.05M | 745.34M | 598.12M | 657.29M | 625.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 769.05M | 745.34M | 598.12M | 657.29M | 625.71M |
| Cost of Revenue | 246.13M | 242.77M | 195.35M | 216.11M | 270.48M |
| Gross Profit | 522.92M | 502.58M | 402.77M | 441.18M | 355.23M |
| SG&A Expenses | 313.59M | 303.47M | 242.74M | 253.39M | 239.81M |
| Depreciation & Amortization | 29.84M | 30.19M | 28.80M | 29.91M | 30.08M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 627.63M | 616.17M | 499.86M | 532.76M | 575.18M |
| Operating Income | 141.42M | 129.17M | 98.26M | 124.53M | 50.53M |
| Income Before Tax | 143.99M | 188.17M | 103.67M | 24.67M | 57.03M |
| Income Tax Expenses | 25.03M | -14.67M | 28.21M | -1.84M | 5.20M |
| Earnings from Continuing Operations | 118.97M | 202.85M | 75.46M | 26.51M | 51.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 118.97M | 202.85M | 75.46M | 26.51M | 51.84M |
| EBIT | 141.42M | 129.17M | 98.26M | 124.53M | 50.53M |
| EBITDA | 212.62M | 199.85M | 164.40M | 192.76M | 117.67M |
| EPS Basic | 0.88 | 1.50 | 0.55 | 0.19 | 0.38 |
| Normalized Basic EPS | 0.67 | 0.60 | 0.48 | 0.40 | 0.27 |
| EPS Diluted | 0.88 | 1.49 | 0.54 | 0.19 | 0.38 |
| Normalized Diluted EPS | 0.67 | 0.60 | 0.47 | 0.40 | 0.27 |
| Average Basic Shares Outstanding | 134.50M | 135.21M | 136.76M | 136.73M | 135.62M |
| Average Diluted Shares Outstanding | 135.39M | 136.50M | 139.77M | 139.71M | 138.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |